E. Ohman J:or Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$580K Hold
40,000
0.01% 390
2026
Q1
$554K Buy
40,000
+7,000
+21% +$97.5K 0.01% 375
2025
Q4
$463K Sell
33,000
-8,000
-20% -$112K 0.01% 437
2025
Q3
$573K Hold
41,000
0.01% 352
2025
Q2
$616K Sell
41,000
-7,000
-15% -$100K 0.02% 337
2025
Q1
$633K Hold
48,000
0.02% 338
2024
Q4
$758K Hold
48,000
0.02% 324
2024
Q3
$763K Sell
48,000
-9,000
-16% -$145K 0.02% 310
2024
Q2
$869K Hold
57,000
0.02% 273
2024
Q1
$836K Buy
57,000
+1,500
+3% +$21.9K 0.02% 278
2023
Q4
$772K Sell
55,500
-20,000
-26% -$267K 0.03% 268
2023
Q3
$1.01M Sell
75,500
-13,500
-15% -$183K 0.04% 240
2023
Q2
$1.12M Buy
89,000
+9,000
+11% +$105K 0.04% 240
2023
Q1
$911K Hold
80,000
0.04% 259
2022
Q4
$828K Sell
80,000
-4,000
-5% -$43.2K 0.04% 272
2022
Q3
$879K Hold
84,000
0.04% 249
2022
Q2
$931K Sell
84,000
-29,000
-26% -$315K 0.04% 243
2022
Q1
$1.26M Buy
113,000
+13,000
+13% +$147K 0.04% 241
2021
Q4
$1.31M Buy
+100,000
New +$1.26M 0.04% 256

Other funds holding RDY

E. Ohman J:or Asset Management's RDY Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 40,000 shares worth $580K. The position accounts for 0.01% of the portfolio, ranked #390.

E. Ohman J:or Asset Management first reported a position in RDY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.31M in Q4 2021. 114 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • E. Ohman J:or Asset Management held 40,000 shares of Dr. Reddy's Laboratories worth $580K as of Q2 2026.
  • E. Ohman J:or Asset Management left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.01% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #390 holding.
  • E. Ohman J:or Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 19 quarters since.
  • E. Ohman J:or Asset Management's Dr. Reddy's Laboratories position peaked at $1.31M in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.